Subscribe for real-time financial insights on Trade Target’s WhatsApp Channels
Ambey Laboratories, founded in 1985, makes products to protect crops. For nearly 40 years, the company has been producing and supplying chemicals like 2,4-D used in agriculture.
Ambey Laboratories IPO Overview
Ambey Laboratories is launching its IPO aiming to raise ₹44.68 crores. The issue is a combination of fresh issue of ₹42.55 crores and OFS of ₹2.12 crores. IPO subscription opens on 4 July 2024 and closes on 8 July 2024. The allotment is expected to be finalized on 9 July 2024 with shares set to list on NSE SME on 11 July 2024. The price range for IPO is set between ₹65 to ₹68 per share and minimum application size is 2000 shares.
The company’s promoter, Archit Gupta, Arpit Gupta, Sarina Gupta and Rishita Gupta currently holds 94.97% stake which will reduce post issue. Registrar of Ambey Lab IPO is Link Intime India Private
Ambey Laboratories IPO GMP
Ambey Laboratories SME IPO’s latest grey market premium (GMP) is ₹0 as of 30 June 2024. Given the upper price band of ₹68, the estimated listing price is ₹68 (cap price + today’s GMP). This suggests an expected gain of 0% per share.
Stay tuned with Trade Target for daily updates on Ambey Laboratories IPO GMP and the expected listing price.
- Date: 3 – July – 2024
- Ambey Laboratories GMP: ₹33 (48.53%)
- Date: 2 – July – 2024
- Ambey Laboratories GMP: ₹27 (39.71%)
- Date: 1 – July – 2024
- Ambey Laboratories GMP: ₹22 (32.35%)
- Date: 30 – June – 2024
- Ambey Laboratories GMP: ₹0 (0%)
How can one apply for Ambey Laboratories IPO?
Ambey Laboratories’s IPO requires investors to bid for a minimum of 2000 shares.The table below lists the minimum and maximum number of shares that retail investors and high net worth individuals (HNIs) can buy along with the corresponding investment amounts.
| Application | Lots | Shares | Amount |
|---|---|---|---|
|
Retail (Min) |
1 |
2000 |
₹136,000
|
|
Retail (Max) |
1 |
2000 |
₹136,000
|
|
S-HNI (Min) |
2 |
4000 |
₹272,000
|
Ambey Laboratories IPO Financial
Ambey Laboratories Limited has shown financial growth over the past 3years. Check the summary of Ambey Laboratories financial performance for the periods ending on March 31 of each year.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
|
Assets in (₹ Lakhs) |
8,620.84
|
5,761.85
|
5,592.94
|
|
Revenue (₹ Lakhs) |
10,043.69
|
10,743.47
|
8,511.19
|
|
PAT (₹ Lakhs)
|
607.73
|
456.93
|
357.47
|
|
Total Borrowing (₹ Lakhs)
|
607.73
|
456.93
|
357.47
|
Ambey Laboratories Vs Peers
In the table below you can see that Ambey Laboratories has the lowest EPS among its peers which is not a good sign.
| Company | EPS Basic | P/E(x) |
|---|---|---|
|
Ambey Laboratories Limited
|
2.57
|
- |
|
Atul Ltd
|
187.05
|
46.9
|
|
Meghmani Organics Ltd.
|
9.85
|
63.21
|
Ambey Laboratories IPO Quota allocation
- QIB Investor: 50% of the net issue
- Retail Investor: 35% of the net issue
- NII (HNI) Investor: 15% of the net issue
Expected Listing Date for Ambey Laboratories IPO
- Subscription Period: 4 July to 8 July
- Basis of Allotment Finalization: 9 July 2024
- Initiation of Refunds: 10 July 2024
- Demat Credits: 10 July 2024
- Listing Date: 11 July 2024
- Listing on: NSE SME
